secwatch.observer — SEC 8-K summary
======================================

Issuer:     CareDx, Inc. (CDNA)
CIK:        0001217234
Form:       8-K
Filed at:   2024-02-28T23:59:59+00:00
Accession:  0001217234-24-000032
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01, 7.01
LLM model:  deepseek-v4-flash:cloud@v2

CareDx reports FY2023 revenue $280.3M, exceeding guidance; Q4 net loss includes $96.3M patent accrual
--------------------------------------------------------------------------------

- Full-year revenue $280.3M, down 13% YoY; Testing Services revenue $209.7M, down 20%.
- Q4 revenue $65.6M, down 20% YoY; net loss $118.1M, including $96.3M patent infringement accrual.
- Non-GAAP net loss per share Q4 $0.17; full-year adjusted EBITDA loss $38.0M.
- Cash and marketable securities $235.4M; repurchased 2.9M shares for $27.5M in 2023.
- Seeking judicial review of January 2024 jury verdict on patent ‘544; Medicare coverage added for HeartCare and AlloSure Lung.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1217234/000121723424000032/0001217234-24-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1217234/000121723424000032/cdna-20240228.htm
  HTML page:      https://secwatch.observer/filing/0001217234-24-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer